Review article · 2020 · Open access

Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa

Aditi Arya, Loick Pradel Kojom Foko, Shewta Chaudhry, Amit Kumar Sharma, Vineeta Singh

International Journal for Parasitology Drugs and Drug Resistance, 15, 43–56 · Published 13 December 2020 · DOI 10.1016/j.ijpddr.2020.11.006

Open PDFView at the publisherCite this paper

In brief

“Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa” is a 2020 review article by Aditi Arya and 4 co-authors, published in International Journal for Parasitology Drugs and Drug Resistance. OpenAlex counts 134 citations as of 19 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at International Journal for Parasitology Drugs and Drug Resistance.

Citations
134
Most cited in
2024 (32)
Field-weighted impact
2.09
References
150
Authors
5

Abstract

Artemisinin-based combination therapies (ACT) are currently used as a first-line malaria therapy in endemic countries worldwide. This systematic review aims at presenting the current scenario of drug resistance molecular markers, either selected or involved in treatment failures (TF) during in vivo ACT efficacy studies from sub-Saharan Africa (sSA) and India. Eight electronic databases were comprehensively used to search relevant articles and finally a total of 28 studies were included in the review, 21 from sSA and seven from India. On analysis, Artemether + lumefantrine (AL) and artesunate + sulfadoxine-pyrimethamine (AS + SP) are the main ACT in African and Indian regions with a 28-day efficacy range of 54.3-100% for AL and 63-100% for AS + SP respectively. It was observed that mutations in the Pfcrt (76T), Pfdhfr (51I, 59R, 108N), Pfdhps (437G) and Pfmdr1 (86Y, 184F, 1246Y) genes were involved in TF, which varied with respect to ACTs. Based on studies that have genotyped the Pfk13 gene, the reported TF cases, were mainly linked with mutations in genes associated with resistance to ACT partner drugs; indicating that the protection of the partner drug efficacy is crucial for maintaining the efficacy of ACT. This review reveals that ACT are largely efficacious in India and sSA despite the fact that some clinical efficacy and epidemiological studies have reported some validated mutations (i.e., 476I, 539T and 561H) in circulation in these two regions. Also, the role of PfATPase6 in ART resistance is controversial still, while P. falciparum plasmepsin 2 (Pfpm2) in piperaquine (PPQ) resistance and dihydroartemisinin (DHA) + PPQ failures is well documented in Southeast Asian countries but studied less in sSA. Hence, there is a need for continuous molecular surveillance of Pfk13 mutations for emergence of artemisinin (ART) resistance in these countries.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Arya, A., Foko, L. P. K., Chaudhry, S., Sharma, A. K., & Singh, V. (2020). Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa. International Journal for Parasitology Drugs and Drug Resistance, 15, 43–56. https://doi.org/10.1016/j.ijpddr.2020.11.006

MLA 9

Arya, Aditi, et al. “Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa.” International Journal for Parasitology Drugs and Drug Resistance, vol. 15, 2020, pp. 43–56. https://doi.org/10.1016/j.ijpddr.2020.11.006.

Chicago

Arya, Aditi, Loick Pradel Kojom Foko, Shewta Chaudhry, Amit Kumar Sharma, and Vineeta Singh. 2020. “Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa.” International Journal for Parasitology Drugs and Drug Resistance 15: 43–56. https://doi.org/10.1016/j.ijpddr.2020.11.006.

Harvard

Arya, A. et al. (2020) ‘Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa’, International Journal for Parasitology Drugs and Drug Resistance, 15, pp. 43–56. doi:10.1016/j.ijpddr.2020.11.006.

IEEE

A. Arya, L. P. K. Foko, S. Chaudhry, A. K. Sharma, and V. Singh, “Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa,” International Journal for Parasitology Drugs and Drug Resistance, vol. 15, pp. 43–56, 2020, doi: 10.1016/j.ijpddr.2020.11.006.

BibTeX

@article{arya2020artemisinin,
  title     = {{Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa}},
  author    = {Arya, Aditi and Foko, Loick Pradel Kojom and Chaudhry, Shewta and Sharma, Amit Kumar and Singh, Vineeta},
  journal   = {International Journal for Parasitology Drugs and Drug Resistance},
  year      = {2020},
  volume    = {15},
  pages     = {43--56},
  doi       = {10.1016/j.ijpddr.2020.11.006},
  url       = {https://doi.org/10.1016/j.ijpddr.2020.11.006}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202011
20211010
20222424
20232727
20243232
20252525
20261515

Its field-weighted citation impact is 2.09: it has been cited 2.09 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control

  • artemisinin-based combination therapy
  • antimalarial drug resistance
  • Plasmodium falciparum
  • pfk13 mutations
  • pfcrt
  • pfdhfr
  • pfdhps
  • pfmdr1

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Arya, A., Foko, L. P. K., Chaudhry, S., Sharma, A. K., & Singh, V. (2020). Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa. International Journal for Parasitology Drugs and Drug Resistance, 15, 43–56. https://doi.org/10.1016/j.ijpddr.2020.11.006

How many times has this paper been cited?

134 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at International Journal for Parasitology Drugs and Drug Resistance: sign in and open the PDF from this page.

Who wrote this paper?

Aditi Arya, Loick Pradel Kojom Foko, Shewta Chaudhry, Amit Kumar Sharma, Vineeta Singh.

What is the DOI of this paper?

10.1016/j.ijpddr.2020.11.006, permanently at https://doi.org/10.1016/j.ijpddr.2020.11.006. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.